Indonesia: Draft patent law discussed

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Indonesia: Draft patent law discussed

A parliamentary committee of Indonesia's House of People's Representatives (Dewan Perwakilan Rakyat (DPR)) is reviewing and discussing a draft patent law.

The draft patent law has been placed in the 2016 National Legislative Program (Prolegnas) of the DPR as one of the prioritised pieces of legislation for 2016. The new patent law is expected to be enacted in the first half of 2016.

We highlight below some key points of the September 2015 draft amendment to the draft patent law.

No data exclusivity rules

The draft patent law provides that if an invention is related to genetic resources and/or traditional knowledge, the source of those genetic resources and/or traditional knowledge must be mentioned clearly and properly.

Subject matter not regarded as invention

Under the current law, rules and methods about computer programs are not considered as inventions. In the draft patent law, this has been amended to rules and methods that only comprise computer programs. This amendment opens the possibility of computer-related inventions being protected as patents.

One other subject matter added to those that are not regarded as inventions is discovery in the forms of (1) new use of a known product, and (2) new forms of existing compounds that show no increase of efficacy.

Substantive examination

The draft patent law provides that the substantive examination can be done by examiners and also by outsourced experts. The purpose is to increase the quality of the examination, and to provide a skilled workforce for fields that have not been controlled by examiners.

Compulsory licence and government use

The draft patent law provides more clarity on the ruling of compulsory licences and government use.

For compulsory licences, the new ruling will include, among other things, (1) reasons for the delay in providing decisions on compulsory licences; (2) new timeframe for decisions to grant or reject compulsory licence applications, (3) the state's approval to export patented products to other developing or less developed countries that are in need of certain pharmaceutical products due to endemic diseases by request of those countries, and (4) compulsory licences regarding semiconductor technology.

For implementation of patents by the government, the proposed amendment will limit the government's implementation of patents for domestic needs to non-commercial purposes.

The government's implementation of patents in connection with state defence and security includes firearms, ammunition, military explosives, interception, tapping, reconnaissance, encryption, or other processes and apparatuses for the state's defence and security. For urgent needs for the public interest, the government's use of patents will include (a) pharmaceutical and/or biotechnology products for endemic diseases; (b) chemical and/or biotechnology products in agriculture for food security; (c) veterinary medicines to tackle endemic pests and animal diseases; (d) processes and/or products to tackle natural disasters and/or environmental disasters.

Extension of Bolar provision

The draft patent law amends the number of years for a third party to use a patented invention for the purpose of carrying out tests, preparing for production, and seeking regulatory/marketing approval before the patent expires, from two years to three years.

Further amendments to the draft patent law are still possible at this stage, as the parliamentary committee is still open to comments on the draft patent law.

Lukiantono_Daru
Purnamasari

Daru Lukiantono

Primastuti Purnamasari


Hadiputranto, Hadinoto & PartnersThe Indonesia Stock Exchange Building, Tower II, 21st FloorSudirman Central Business DistrictJl. Jendral Sudirman Kav 52-53Jakarta 12190, IndonesiaTel: +62 21 2960 8888Fax: +62 21 2960 8999www.hhp.co.id

more from across site and SHARED ros bottom lb

More from across our site

Licensing chief Patrik Hammarén also reveals that the company will rename its IPR business to better reflect its role in defining standards
The acquisition of Pecher & Partners follows the firm’s earlier expansion into litigation to create a ‘one-stop shop’
News of Via Licensing Alliance launching its first semiconductor patent pool and INTA electing a new president were also among the top talking points
Submit your nominations to this year's WIBL Americas Awards by January 23
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works
Xia Zheng, founder of AFD China, discusses balancing legal work with BD, new approaches to complex challenges, and the dangers of ‘over-optimism’
A dispute involving semiconductor technology and a partner's move from Hoffman Eitle to Hoyng Rokh Monegier were also among the top talking points
Gift this article